from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0346c/ansP2

LFCtreatmentdescriptionclass of inhibitor

-1.829

Amikacinug/mL Amikacintranslation

-1.827

Cap5-10ug/mL Capreomycintranslation

-2.938

Rox10-50 ug/mL Roxithromycintranslation

0.002

SM2-5 ug/mL Streptomycintranslation

-3.091

Tet5-10 ug/mL Tetracyclinetranslation

-1.396

Rif0.2-5ug/mL Rifampicintranscription

-0.978

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.000

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.271

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.388

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.000

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.394

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.000

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.260

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.691

Nigericin50 uM Nigericinrespiration

-0.418

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

1.555

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.000

menadione6-10 ug/mL Menadionerespiration

0.113

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.589

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.184

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.000

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.000

NRP_1Non-replicating persistence stage 1dosRassociated

0.605

Amp0.2mg/mL AmpicillincellWall

0.665

Cephalexin20-100 ug/mL CephalexincellWall

0.564

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.680

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.136

EMB10-20 ug/mL EthambutolcellWall

0.002

Eta12-40 ug/mL EthionamidecellWall

0.233

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.237

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.255

BZA0.12 mg/mL BenzamidearomaticAmides

-0.190

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.232

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.311

H2O24 mM hydrogen peroxideDNAdamaging

1.338

Levo10 ug/mL LevofloxacinDNAdamaging

0.402

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.636

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.565

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.976

Antimycin12.5-50 ug/mL Antimycin A?

0.000

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.192

PA_110-50 ug/mL Antitubercular compound PA-1?

1.513

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.362

PA8240.2-2 ug/mL PA-824?

-0.935

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.174

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

0.000

mercaptoethanol2 mM 2-Mercaptoethanol?

0.000

methoxatin10-20 ug/mL Methoxatin?